Connect with us

Hi, what are you looking for?

Wednesday, May 31, 2023
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Aurora partners with Strainprint to support medical cannabis patients journey

The app will help patients figure out which is the best dose, cultivar, THC/CBD ratio and methods that better work for them

Aurora launches app to track medical cannabis patients progress
Strainprint allows tracking of cannabis usage. Photo via Strainprint.

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has partnered with a cannabis use tracking app to help patients understand which cultivars, THC/CBD levels, methods and doses work best for them.

On Wednesday, the cannabis giant announced the partnership with Strainprint App which will be used by patients to journal and log their symptoms and consumption habits. Patients can also explore new products and see what has helped other patients in the past.

“We take a patient-first approach to cannabis and are proud to provide our patients with programs that improve their lives and their medical cannabis journey,” says Mike Jones, SVP of Medical at Aurora Cannabis.

“By working with Strainprint, we can support our patients every step of the way, and further Aurora’s promise to prioritize patient well-being and provide the highest quality products.”

Strainprint is an analytics technology platform that has provided data to patients, doctors, licensed producers, retailers, industry regulators, academic researchers and pharmaceutical/biotechnology companies across Canada, the U.S., AustraliaIsrael and New Zealand. The app has been used to track information about cannabis consumption in previous clinical studies.

Read more: Aurora Cannabis expands Australian portfolio with new high THC product

Read more: Tilray reports $1.1B in losses during Q3 2023, acquires Hexo for $75M

Last August, Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) released launched CannaPoints under the Strainprint App, a new program designed to support patients through their medical cannabis journey. Patients are also able to earn points via the app and get discounts for products.

Other cannabis usage tracking apps include Releaf which offers similar information to patients.


Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


Clever Leaves and its Swiss distribution partner Astrasana are also planning to distribute the extracts in the Czech Republic


The market for the cannabinoid was worth approximately US$8.33 billion this year


The company will be supporting the cancer and patient care conference ONCOWELLNESS


The company received its fifth GMP certification from the European Union, Colombia and Brazil